• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. Journal of Pharmacology and Toxicology
  2. Vol 1 (2), 2006
  3. 115-125
  • Issues
    Online First Current Issue All Issues
  • Information About
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

Journal of Pharmacology and Toxicology

Year: 2006 | Volume: 1 | Issue: 2 | Page No.: 115-125
DOI: 10.3923/jpt.2006.115.125

Facebook Twitter Reddit Linkedin E-mail
Google Scholar ASCI
Research Article

Interactions of Cyclooxygenase Inhibitors with Reactive Oxygen Species

Sheikh A. Saeed
Dr. Panjwani Center for Molecular Medicine and Drug Research, Intemational Center for Chemical Sciences, University of Karachi, Karachi-7 5270, Pakistan

Muhammad A. Mesaik
Dr. Panjwani Center for Molecular Medicine and Drug Research, Intemational Center for Chemical Sciences, University of Karachi, Karachi-7 5270, Pakistan

J. Quadri
Dr. Panjwani Center for Molecular Medicine and Drug Research, Intemational Center for Chemical Sciences, University of Karachi, Karachi-7 5270, Pakistan

S. Tasneem
Dr. Panjwani Center for Molecular Medicine and Drug Research, Intemational Center for Chemical Sciences, University of Karachi, Karachi-7 5270, Pakistan

A. Motiwala
Dr. Panjwani Center for Molecular Medicine and Drug Research, Intemational Center for Chemical Sciences, University of Karachi, Karachi-7 5270, Pakistan

U. Khalid
Dr. Panjwani Center for Molecular Medicine and Drug Research, Intemational Center for Chemical Sciences, University of Karachi, Karachi-7 5270, Pakistan

Syed U. Ali
Dr. Panjwani Center for Molecular Medicine and Drug Research, Intemational Center for Chemical Sciences, University of Karachi, Karachi-7 5270, Pakistan

Faisal Hussain
Dr. Panjwani Center for Molecular Medicine and Drug Research, Intemational Center for Chemical Sciences, University of Karachi, Karachi-7 5270, Pakistan

Muhammad I. Choudhary
Dr. Panjwani Center for Molecular Medicine and Drug Research, Intemational Center for Chemical Sciences, University of Karachi, Karachi-7 5270, Pakistan

Reactive oxygen species (ROS) are a natural means of defense in the body produced mainly by phagocytic and mast cells. However, their overproduction plays an important role in the pathogenesis of numerous diseases, such as atherosclerosis, cancer, myocardial infarction (MI) and other chronic inflammatory diseases. This review attempts to present our understanding in the interaction of anti-inflammatory drugs with ROS. It has been proposed that in addition to inhibition of prostaglandin synthesis, the anti-inflammatory actions of non-steroidal anti-inflammatory drugs (NSAIDs) may also be due to their free radical scavenging effect. The action of NSAIDs has been demonstrated against an array of ROS, including O-2, OH-, HOCl, as well as various Reactive Nitrogen Species (RNS) such as nitric oxide (NO) and peroxynitrite (ONOO)-. NSAIDs are thought to compete with chloride for the active site of myeloperoxidase (MPO), thereby inhibiting HOCl strong oxidant radical production.
PDF Fulltext XML References

How to cite this article

Sheikh A. Saeed, Muhammad A. Mesaik, J. Quadri, S. Tasneem, A. Motiwala, U. Khalid, Syed U. Ali, Faisal Hussain and Muhammad I. Choudhary, 2006. Interactions of Cyclooxygenase Inhibitors with Reactive Oxygen Species. Journal of Pharmacology and Toxicology, 1: 115-125.

DOI: 10.3923/jpt.2006.115.125

URL: https://scialert.net/abstract/?doi=jpt.2006.115.125

Leave a Comment


Your email address will not be published. Required fields are marked *

Article Trend



Total views 3734

References


  1. Andersen, K., L.J. Launer, A.W. Hoes, M.M. Breteler and A. Hofman, 1995. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The rotterdam study. Neurology, 45: 1441-1445.
    Direct Link

  2. Asanuma, M., S. Nishibayashi-Asanuma, I. Miyazaki, M. Kohno and N. Ogawa, 2001. Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals. J. Neurochem., 76: 1895-1904.
    CrossRefDirect Link

  3. Basu, S., E. Rudolph and T.X. Huang, 2001. Theorized mechanism of non-steroidal anti-inflammatory drugs against alzheimer's disease onset and progression. JYI, 3: 1-8.
    Direct Link

  4. Bauer, H. and E. Marker-Hermann, 2003. Therapy with non-steroidal anti-inflammatory drugs. Orthopade, 32: 1088-1094.

  5. Bonnefont-Rousselot, D., J.P. Bastard, M.C. Jaudon and J. Delattre, 2000. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab., 26: 163-176.
    PubMedDirect Link

  6. Costa, D., A. Gomes, S. Reis, J.L. Lima and E. Fernandes, 2005. Hydrogen peroxide scavenging activity by non-steroidal anti-inflammatory drugs. Life Sci., 76: 2841-2848.
    CrossRef

  7. Cotelle, P., N. Cotelle, E. Teissier and V.H. Vezin, 2003. Synthesis and antioxidant properties of a new lipophilic ascorbic acid analogue. Med. Chem., 11: 1087-1093.
    CrossRef

  8. Dahlgren, C. and A. Karlsson, 1999. Respiratory burst in human neutrophils. J. Immunol. Meth., 232: 3-14.
    PubMed

  9. Derevianko, A., T. Graeber, R. D'Amico and H.H. Simms, 1998. The role of neutrophil-derived oxidants as second messengers in interleukin 1Beta-stimulated cells. Shock, 10: 54-61.
    Direct Link

  10. Dragomir, E., I. Manduteanu, M. Voinea, G. Costache, A. Manea and M. Simionescu, 2002. Aspirin rectifies calcium homeostasis, decreases reactive oxygen species and increases NO production in high glucose-exposed human endothelial cells. J. Diabetes Complicat., 18: 289-299.
    Direct Link

  11. Dusting, G.J., S. Selemidis and F. Jiang, 2005. Mechanisms for suppressing NADPH oxidase in the vascular wall. Mem. Inst. Oswaldo. Cruz., 100: 97-103.
    Direct Link

  12. El-Benna, J., P.M.C. Dang, M.A. Gougerot-Pocidalo and C. Elbim, 2005. Phagocyte NADPH oxidase: A multicomponent enzyme essential for host defenses. Arch. Immunol. Ther. Exp. (Warsz)., 53: 199-206.
    Direct Link

  13. El-Midaoui, A., R. Wu and J. de Champlain, 2002. Prevention of hypertension, hyperglycemia and vascular oxidative stress by aspirin treatment in chronically glucose-fed rats. J. Hypertens., 20: 1407-1412.
    Direct Link

  14. Fernandes, E., D. Costa, S.A. Toste, J.L. Lima and S. Reis, 2004. In vitro scavenging activity for reactive oxygen and nitrogen species by non steroidal anti-inflammatory indole, pyrrole and oxazole derivative drugs. Free Radic. Biol. Med., 37: 1895-1905.
    PubMed

  15. Froman, H.J. and Boveris, 1982. Superoxide Radical and Hydrogen Peroxide in Mitochondria. In: Free Radicals in Biology, Pryor, W.A. (Ed.). Vol. 5, Academic Press, New York, pp: 65-90.

  16. Galleron, S., D. Borderie, C. Ponteziere, H. Lemarechal and M. Jambou et al., 1999. Reactive oxygen species induce apoptosis of synoviocytes in vitro. A-Tocopherol provides no protection. Cell Biol. Int., 23: 637-642.
    CrossRef

  17. Gonzalez, A., M.P. Granados, G.M. Salido and J.A. Pariente, 2005. H2O2-induced changes in mitochondrial activity in isolated mouse pancreatic acinar cells. Mol. Cell. Biochem., 269: 165-173.
    Direct Link

  18. Gulow, K., M. Kaminski, K. Darvas, D. Suss, M. Li-Weber and P.H. Krammer, 2005. HIV-1 trans-activator of transcription substitutes for oxidative signaling in activation-induced T cell death. J. Immunol., 174: 5249-5260.
    Direct Link

  19. Helfand, S.L., J. Werkmeister and J.C. Roder, 1982. Chemiluminescence response of human natural killer cells. I. The relationship between target cell binding, chemiluminescence and cytolysis. J. Exp. Med., 156: 492-505.
    Direct Link

  20. Hildeman, D.A., T. Mitchell, T.K. Teague, P. Henson, B.J. Day, J. Kappler and P.C. Marrack, 1999. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity, 10: 735-744.
    PubMed

  21. Holecek, V., J. Liska, J. Racek and R. Rokyta, 2004. The significance of free radicals and antioxidants due to the load induced by sport activity. Cesk. Fysiol., 53: 76-79.
    PubMed

  22. Hundal, R.S., K.F. Petersen, A.B. Mayerson, P.S. Randhawa, S. Inzucchi, S.E. Schoelsen and G.I. Schulman, 2002. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J. Clin. Invest., 109: 1321-1326.
    CrossRefPubMed

  23. Imlay, J.A., 2003. Pathways of oxidative damage. Ann. Rev. Microbiol., 57: 395-418.
    PubMed

  24. Inoguchi, T., P. Li, F. Umeda, H.Y. Yu and M. Kakimoto et al., 2000. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes, 49: 1939-1945.
    CrossRefDirect Link

  25. Jaimes, E.A., R.X. Tian, D. Pearse and L. Raij, 2005. Up-regulation of glomerular COX-2 by angiotensin II: Role of reactive oxygen species. Kidney Int., 68: 2143-2153.

  26. Ju, C. and J.P. Uetrecht, 1998. Oxidation of a metabolite of indomethacin (desmethyldeschlorobenzoylindomethacin) to reactive intermediates by activated neutrophils, hypochlorous acid and the myeloperoxidase system. Drug Metab. Dispos., 26: 676-680.

  27. Kampf, C. and G.M. Roomans, 2001. Effect of hypochlorite on cultured respiratory epithelial cells. Free Radic. Res., 34: 499-511.

  28. Kast, R.E., 2000. Tumor necrosis factor has positive and negative self-regulatory feed back cycles centered around cAMP. Int. J. Immunopharmacol., 22: 1001-1006.

  29. Kast, R.E., 2000. Non-steroidal anti-inflammatory drugs might also be pro-inflammatory by increasing tumor necrosis factor. Biomed. Pharmacother, 54: 168-169.

  30. Kato, Y., A. Nagao, J. Terao and T. Osawa, 2003. Inhibition of myeloperoxidase-catalyzed tyrosylation by phenolic antioxidants in vitro. Biosci. Biotechnol. Biochem., 67: 1136-1139.

  31. Lander, H.M., 1997. An essential role for free radicals and derived species in signal transduction. FASEB J., 11: 118-124.

  32. Lee, J., N. Koo and D.B. Min, 2004. Reactive oxygen species, aging and antioxidative nutraceuticals. Comp. Rev. Food Sci. Food Saf., 3: 21-33.
    CrossRefDirect Link

  33. Long, H., T. Shi, P.J. Borm, J. Maatta, K. Husgafvel-Pursiainen, K. Savolainen and F. Krombach, 2004. ROS-mediated TNF-alpha and MIP-2 gene expression in alveolar macrophages exposed to pine dust. Part. Fibre Toxicol., 13: 1-3.
    PubMed

  34. Los, M., H. Schenk, K. Hexel, P.A. Baeuerle, W. Droge and K.S. Osthoff, 1995. IL-2 gene expression and NF-κB activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J., 14: 3731-3740.
    Direct Link

  35. Lu, Y. and L.M. Wahl, 2005. Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2 and prostaglandin E2 through enhancement of NF-{kappa}B Activity in lipopolysaccharide-activated human primary monocytes. J. Immunol., 175: 5423-5429.
    Direct Link

  36. Matyas, S., V. Pucovsky and V. Bauer, 2002. Effects of various reactive oxygen species on the guinea pig trachea and its epithelium. Jap. J. Pharmacol., 88: 270-278.
    Direct Link

  37. Metnitz, P.G., C. Bartens, M. Fischer, P. Fridrich, H. Stelzer and W. Drunl, 1999. Antioxidant status in patients with acute respiratory distress syndrome. Int. Care Med., 25: 180-185.
    Direct Link

  38. Meyer, J.W. and M.E. Schmitt, 2000. A central role for the endothelial NADPH oxidase in atherosclerosis. FEBS Lett., 472: 1-4.
    Direct Link

  39. Moore, D.J., A.B. West, V.L. Dawson and T.M. Dawson, 2005. Molecular pathophysiology of parkinson's disease. Ann. Rev. Neurosci., 28: 57-87.
    CrossRef

  40. Mouithys-Mickalad, A.M.L., S.X. Zheng, G.P. Deby-Dupont, C.M.T. Deby, M.M. Lamy, J.Y.Y. Reginster and Y.E. Henrotin, 2000. In vitro study of the antioxidant properties of non steroidal anti-inflammatory drugs by chemiluminescence and electron spin resonance (ESR). Free Radic. Res., 33: 607-621.
    CrossRef

  41. Neve, J., N. Parij and N. Moguilevski, 2001. Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs investigated with a human recombinant enzyme. Eur. J. Pharmacol., 417: 37-43.
    CrossRef

  42. Oz, H.S., T.S. Chen, J. de McClain and W.J. de Villiers, 2005. Antioxidants as novel therapy in a murine model of colitis. J. Nutr. Biochem., 16: 297-304.
    Direct Link

  43. Paino, I.M., V.F. Ximenes, L.M. Fonseca, M.P.P. Kanegae, N.M. Khalil and I.L. Brunetti, 2005. Effect of therapeutic plasma concentrations of non-steroidal anti-inflammatory drugs on the production of reactive oxygen species by activated rat neutrophils. Braz. J. Med. Biol. Res., 38: 543-551.
    CrossRef

  44. Plaza, V., J. Prat, J. Rosello, E. Ballester and I. Ramis et al., 1995. In vitro release of arachidonic acid metabolites, glutathione peroxidase and oxygen-free radicals from platelets of asthmatic patients with without aspirin intolerance. Thorax, 50: 490-496.
    Direct Link

  45. Podhaisky, H.P., A. Abate, T. Polte, S. Oberle and H. Schroder, 1997. Aspirin protects endothelial cells from oxidative stress-possible synergism with vitamin E. FEBS Lett, 417: 349-351.
    Direct Link

  46. Quinlan, T.G.J., N.J. Lamb, R. Tilley, T.W. Evans and J.M. Gutteridge, 1997. Plasma hypoxanthine levels in ARDS: Implications for oxidative stress, morbidity and mortality. Am. J. Respir. Crit. Care Med., 155: 479-484.
    Direct Link

  47. Rahimi, R., S. Nikfar, B. Larijani and M. Abdollahi, 2005. A review on the role of antioxidants in the management of diabetes and its complications. Biomed. Pharmacother., 59: 365-373.
    PubMedDirect Link

  48. Saeed, S.A., M.A. Waqar, A.J. Zubairi, H. Bhurgri and A. Khan et al., 2005. Myocardial ischaemia and reperfusion injury: Reactive oxygen species and the role of neutrophil. J. Coll. Physicians Surg. Pak., 15: 507-514.
    PubMed

  49. Saeed, S.A., M. Atiq, S. Virani and A.H. Gilani, 2001. New vistas in the therapeutic uses of aspirin. Res. Commun. Pharmacol. Toxicol., 6: 277-296.

  50. Sano, T., F. Umeda, T. Hashimoto, H. Nawata and H. Utsumi, 1998. Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes. Diabetologia, 41: 1355-1360.
    CrossRef

  51. Schieven, G.L., H. de Fex and Stephenson, 2002. Hypochlorous acid activates tyrosine phosphorylation signal pathways leading to calcium signaling and TNFalpha production. Antioxid. Redox Signal, 4: 501-507.
    PubMed

  52. Schoonbroodt, S., S. Legrand-Poels, M. Best-Belpomme and J. Piette, 1997. Activation of the NF-kappaB transcription factor in a T-lymphocytic cell line by hypochlorous acid. Biochem. J., 321: 777-785.
    PubMedDirect Link

  53. Stolc, S., 1999. Indole derivatives as neuroprotectants. Life Sci., 65: 1943-1950.
    PubMed

  54. Storz, P., 2005. Reactive oxygen species in tumor progression. Front Biosci., 10: 1881-1896.
    PubMed

  55. Sundaresan, M., Z.X. Yu, V.J. Ferrans, K. Irani and T. Fienkel, 1995. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science, 270: 296-299.
    CrossRef

  56. Tan, D.X., R.J. Reiter, L.C. Manchester, M.T. Yan and M. El-Sawi et al., 2002. Chemical and physical properties and potential mechanisms: Melatonin as a broad spectrum antioxidant and free radical scavenger. Curr. Top. Med. Chem., 2: 181-197.
    PubMedDirect Link

  57. Van Antwerpen P. and J. Nave, 2004. In vitro comparative assessment of the scavenging activity against three reactive oxygen species of non-steroidal anti-inflammatory drugs from the oxicam and sulfoanilide families. Eur. J. Pharmacol., 496: 55-61.
    CrossRef

  58. Van Lent, P.L., K.C. Nabbe, A.B. Blom, A. Sloetjes and A.E. Holthuysen et al., 2005. NADPH-oxidase-driven oxygen radical production determines chondrocyte death and partly regulates metalloproteinase-mediated cartilage matrix degradation during interferon-γ-stimulated immune complex arthritis. Arthritis Res. Ther., 7: R885-R895.
    Direct Link

  59. Warner, T.D., F. Giuliano, I. Vojnovic, A. Buksa, J.A. Mitchell and J.R. Vane, 1999. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proc. Natl. Acad. Sci. USA., 96: 7563-7568.
    Direct Link

  60. Weber, G.F., S. Abromson-Leeman and H. Cantor, 1995. A signaling pathway coupled to T cell receptor ligation by MMTV superantigen leading to transient activation and programmed cell death. Immunity, 2: 363-372.
    PubMed

  61. Weber, V., C. Rubat, E. Duroux, C. Lartigue, M. Madesclaire and P. Coudert, 2005. New 3- and 4-hydroxyfuranones as anti-oxidants and anti-inflammatory agents. Bioorg. Med. Chem., 13: 4552-4564.
    Direct Link

  62. Williams, M.S. and P.A. Henkar, 1996. Role of reactive oxygen intermediates in TCR-induced death of T cell blasts and hybridomas. J. Immunol., 157: 2395-2402.
    Direct Link

  63. Westerlund, C., A.M. Ostlund-Lindqvist, M. Sainsbury, H.G. Shertzer and P.O. Sjoquist, 1996. Characterization of novel indenoindoles. Part I. Structure-activity relationships in different model systems of lipid peroxidation. Biochem. Pharmacol., 51: 1397-1402.
    CrossRef

Keywords


  • anti-inflammatory drugs
  • pathological conditions
  • NSAIDs
  • ROS

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved